Andy Roddick defends Serena Williams' GLP-1 weight loss amid comeback talk

Former tennis star Andy Roddick has voiced support for Serena Williams' use of GLP-1 medication in her weight-loss efforts, suggesting it could aid a potential return to the court. Williams has shared how the treatment improved her health, while speculation grows following her inclusion in the anti-doping pool and practice sessions with younger players. Roddick emphasized the benefits for injury prevention during training.

In a recent episode of the Served podcast, Andy Roddick addressed criticism of Serena Williams' use of GLP-1 medication for weight loss. He stated that if he were attempting a comeback, he would prioritize rapid weight reduction to facilitate safer training. "I can tell you something that I think I know for a fact, right? I’m not Serena. I can’t play anymore. I stink. And if I decided that I wanted to come back, guess what I would be doing immediately? Immediately, I’d be dropping 20 pounds as fast as I can," Roddick said.

Roddick argued that starting lighter reduces injury risks during preparation, which is a major hurdle for returning athletes. "I would be taking those drugs because you know what becomes easier when you are 20 pounds lighter? Actually, getting back to the training that you need without getting injured to get back on tour," he explained. He added, "What it does is shortens the timeline for training and mitigates a lot of the risk in because the thing with getting back is like you get injured training, injured training, injured training, you can’t get back. Right."

Williams first discussed her use of the medication in an August 2025 interview with People Magazine and reinforced it in a Super Bowl XL advertisement in 2026. In a January 2026 interview with Today.com, she highlighted health improvements: "My blood sugar is better. I was able to lower my cholesterol by 30%. Some of these numbers [previous high cholesterol levels] are from when I was literally winning Grand Slams. It wasn’t, like, just playing tennis. I was dominating. I was at risk for heart disease, and I didn’t even know. … That’s scary."

Comeback rumors intensified after Williams' name appeared in the tennis anti-doping testing pool, a step often required for returning players. On the Today show in January 2026, she responded ambiguously: "I’m just having fun and enjoying my life right now," adding, "I don’t know, I’m just going to see what happens."

American player Alycia Parks recently practiced with Williams and commented on her fitness. "I actually practiced with her last Monday. And I messaged her yesterday. She’s definitely a good mentor to me, and she’s helped me a lot, especially in my practices," Parks told Tennis Majors. She added, "She is in great shape. So I think she would kill it on tour."

Support for Williams continues to build in the tennis community as discussions of a potential return, possibly emulating sister Venus, persist.

Связанные статьи

Serena Williams, fit and transformed, poses athletically with tennis racket against Super Bowl ad for Zepbound weight loss drug.
Изображение, созданное ИИ

Серена Уильямс снялась в рекламе Super Bowl для препарата для похудения

Сообщено ИИ Изображение, созданное ИИ

Серена Уильямс появится в рекламе Super Bowl, продвигающей телемедицинскую компанию Ro и ее препарат GLP-1 для снижения веса Zepbound. Легенда тенниса 44 лет рассказывает о трансформации тела, потеряв до 15,4 кг с начала лечения. Реклама выходит на фоне спекуляций о возможном возвращении в профессиональный теннис.

Международное агентство по целостности тенниса (ITIA) официально восстановило Серену Уильямс как активную игроку, исключив её из списка retired 22 февраля 2026 года. Этот шаг следует за её возвращением в пул антидопинговых тестов в прошлом году, что делает её eligible для турниров. Её бывший тренер Рик Макки выразил уверенность в возвращении, ссылаясь на её интенсивные тренировки.

Сообщено ИИ

Country star Jelly Roll has dropped nearly 300 pounds over two years without using popular GLP-1 medications like Ozempic. The 41-year-old singer opened up in Men's Health about tackling his food addiction through therapy instead. From low testosterone woes to reignited romance, he's spilling all the transformative tea.

Three Cochrane reviews commissioned by the World Health Organization evaluate GLP-1 receptor agonists like tirzepatide, semaglutide, and liraglutide for weight loss in people with obesity. The drugs show substantial weight reduction compared to placebo, but researchers note limitations in long-term data and industry funding influences. Side effects such as nausea are common, raising questions about broader access and safety.

Сообщено ИИ

Вылет Коко Гауфф в четвертьфинале Australian Open 2026 стал скандальным, когда видео, на котором она разбивает ракетку, стало вирусным. Легенда тенниса Серена Уильямс выразила поддержку, в то время как несколько игроков выразили обеспокоенность конфиденциальностью в зонах игроков. Инцидент подчеркнул эмоциональное давление, с которым сталкиваются спортсмены.

Лучшие теннисисты Карлос Алкарас, Янник Синнер и Арина Сабаленка получили указание снять свои фитнес-трекеры Whoop во время Australian Open 2026. Устройства, одобренные для туров ATP и WTA, остаются запрещенными на Grand Slam в разгар дебатов о благополучии игроков и правилах данных. Организаторы турнира ведут обсуждения о возможном разрешении в будущем.

Сообщено ИИ

Retired tennis player Eugenie Bouchard has discussed the upheaval in her life following her 2014 Wimbledon final appearance, which brought sudden fame and high expectations. She described a rebellious phase that included a drastic hairstyle change, leading to the loss of a sponsorship deal. Now focused on pickleball, Bouchard emphasizes the complexity beyond her public image.

 

 

 

Этот сайт использует куки

Мы используем куки для анализа, чтобы улучшить наш сайт. Прочитайте нашу политику конфиденциальности для дополнительной информации.
Отклонить